INTRODUCTION: Previous research has demonstrated that many women with ductal carcinoma in situ (DCIS) overestimate their risk for future breast cancer at the time of diagnosis and soon thereafter. This study aims to evaluate risk perceptions after 5 years. PATIENTS AND METHODS: In a longitudinal cohort study, we mailed long-term follow-up surveys to 315 women who had previously responded to a survey 18 months after they were diagnosed with DCIS, excluding those who had experienced recurrence and those not treated at our institution. We evaluated risk perceptions with items used previously in the cohort. RESULTS: One hundred ninety-three women (61%) responded. The median time since diagnosis was 5.9 years. We excluded 12 because of recurrence. Of the 181 remaining, 32% perceived at least a moderate 5-year risk for developing DCIS again, 43% perceived at least a moderate lifetime risk for developing DCIS again, 27% perceived at least a moderate 5-year risk for invasive breast cancer, 38% perceived at least a moderate lifetime risk for invasive breast cancer, and 24% perceived at least a moderate risk for DCIS spreading to other body parts. In a multivariate model, worse financial status and higher perceived risk in the previous survey were the only predictors of at least a moderate perception of risk for DCIS spreading. CONCLUSION: Women with a history of DCIS continue to harbor inaccurate perceptions of their risk for future breast cancer events even 5 years after diagnosis.
INTRODUCTION: Previous research has demonstrated that many women with ductal carcinoma in situ (DCIS) overestimate their risk for future breast cancer at the time of diagnosis and soon thereafter. This study aims to evaluate risk perceptions after 5 years. PATIENTS AND METHODS: In a longitudinal cohort study, we mailed long-term follow-up surveys to 315 women who had previously responded to a survey 18 months after they were diagnosed with DCIS, excluding those who had experienced recurrence and those not treated at our institution. We evaluated risk perceptions with items used previously in the cohort. RESULTS: One hundred ninety-three women (61%) responded. The median time since diagnosis was 5.9 years. We excluded 12 because of recurrence. Of the 181 remaining, 32% perceived at least a moderate 5-year risk for developing DCIS again, 43% perceived at least a moderate lifetime risk for developing DCIS again, 27% perceived at least a moderate 5-year risk for invasive breast cancer, 38% perceived at least a moderate lifetime risk for invasive breast cancer, and 24% perceived at least a moderate risk for DCIS spreading to other body parts. In a multivariate model, worse financial status and higher perceived risk in the previous survey were the only predictors of at least a moderate perception of risk for DCIS spreading. CONCLUSION:Women with a history of DCIS continue to harbor inaccurate perceptions of their risk for future breast cancer events even 5 years after diagnosis.
Authors: B Fisher; J Dignam; N Wolmark; E Mamounas; J Costantino; W Poller; E R Fisher; D L Wickerham; M Deutsch; R Margolese; N Dimitrov; M Kavanah Journal: J Clin Oncol Date: 1998-02 Impact factor: 44.544
Authors: L L Kestin; N S Goldstein; M D Lacerna; M Balasubramaniam; A A Martinez; M Rebner; J Pettinga; R C Frazier; F A Vicini Journal: Cancer Date: 2000-02-01 Impact factor: 6.860
Authors: B Fisher; J Dignam; N Wolmark; D L Wickerham; E R Fisher; E Mamounas; R Smith; M Begovic; N V Dimitrov; R G Margolese; C G Kardinal; M T Kavanah; L Fehrenbacher; R H Oishi Journal: Lancet Date: 1999-06-12 Impact factor: 79.321
Authors: Ann Partridge; Kristie Adloff; Emily Blood; E Claire Dees; Carolyn Kaelin; Mehra Golshan; Jennifer Ligibel; Janet S de Moor; Jane Weeks; Karen Emmons; Eric Winer Journal: J Natl Cancer Inst Date: 2008-02-12 Impact factor: 13.506
Authors: Ann Partridge; Jeffrey P Winer; Mehra Golshan; Jennifer R Bellon; Emily Blood; E Claire Dees; Ebonie Sampson; Karen M Emmons; Eric Winer Journal: Clin Breast Cancer Date: 2008-06 Impact factor: 3.225
Authors: William Pidduck; Bo Angela Wan; Liying Zhang; Eileen Rakovitch; Selina Chow; Stephanie Chan; Caitlin Yee; Leah Drost; Philomena Sousa; Donna Lewis; Henry Lam; Eric Leung; Edward Chow Journal: Support Care Cancer Date: 2019-08-26 Impact factor: 3.603
Authors: Sherrie Khadanga; Susan G Lakoski; Vicki Hart; Brian L Sprague; Yi Ba; John M Hampton; Stephen T Higgins; Philip A Ades; Polly A Newcomb; Amy Trentham-Dietz Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-06 Impact factor: 4.254
Authors: Sarah T Hawley; Nancy K Janz; Kent A Griffith; Reshma Jagsi; Christopher R Friese; Allison W Kurian; Ann S Hamilton; Kevin C Ward; Monica Morrow; Lauren P Wallner; Steven J Katz Journal: Breast Cancer Res Treat Date: 2016-12-21 Impact factor: 4.624
Authors: Kamaria L Lee; Nancy K Janz; Brian J Zikmund-Fisher; Reshma Jagsi; Lauren P Wallner; Allison W Kurian; Steven J Katz; Paul Abrahamse; Sarah T Hawley Journal: Med Decis Making Date: 2017-08-17 Impact factor: 2.749
Authors: Claire Kim; Laurel Liang; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: Breast Cancer Res Treat Date: 2017-12-23 Impact factor: 4.872
Authors: Lotte E Elshof; Marjanka K Schmidt; Emiel J Th Rutgers; Flora E van Leeuwen; Jelle Wesseling; Michael Schaapveld Journal: Ann Surg Date: 2018-05 Impact factor: 12.969
Authors: Maartje van Seijen; Esther H Lips; Alastair M Thompson; Serena Nik-Zainal; Andrew Futreal; E Shelley Hwang; Ellen Verschuur; Joanna Lane; Jos Jonkers; Daniel W Rea; Jelle Wesseling Journal: Br J Cancer Date: 2019-07-09 Impact factor: 7.640
Authors: Jayden Blackwood; Frances C Wright; Nicole J Look Hong; Anna R Gagliardi Journal: Breast Cancer Res Treat Date: 2019-06-18 Impact factor: 4.872